. 2020 Jul 20;268(2):403–408. doi: 10.1007/s00415-020-10069-1

Table 1.

Incidence-rate ratios of admissions per 7 weeks for suspected stroke and final diagnoses during the COVID-19 pandemic as compared with the pre-COVID-19 period

	COVID-19 cohort (n = 309)	Pre-COVID-19 cohort (n = 407)	Incidence rate ratio (95%CI)
All suspected stroke presentations, n (%)	309	407	0.76 (0.65–0.88)
Ischemic stroke or TIA, n (%)^a	212/309 (69)	248/407 (61)	0.85 (0.71–1.02)
Intracranial hemorrhage, n (%)	20/309 (6)	42/407 (10)	0.48 (0.28–0.81)
Other, n (%)^b	77/309 (25)	115/407 (28)	0.66 (0.50–0.89)

^aNumber of ischemic strokes and TIAs were (COVID-19 vs. pre-COVID-19): ischemic stroke (180 vs. 194), and TIA (32 vs 54)

^bMain other diagnoses (COVID-19 vs pre-COVID-19): seizure (13 vs. 16), peripheral vestibular syndrome (11 vs. 15), benign headache syndromes (4 vs. 5), functional neurological symptoms (11 vs. 15), and cerebral venous thrombosis (0 vs. 2)